This is a great question. So I personally think that CAR T-cell therapies, they do have a meaningful positive impact on quality of life for many myeloma patients, particularly after recovery from the ...

So I think this is one unmet need. Second, I think when we talk about CAR T, a lot of times we need to think what are the deal breakers for CAR T? So when a patient comes to my clinic, the first two ...

By Hugo Francisco de Souza A novel CAR-T cell approach targets amyloid plaques in preclinical Alzheimer models, raising the ...

While interested in CAR-T therapies’ potential to achieve durable, drug-free remission in serious autoimmune conditions, the ...

In part 1 of our interview with Leland Metheny, MD, he explained how a new triple-target chimeric antigen receptor (CAR) T-cell therapy works in multiple myeloma. In part 1 of our interview with ...

A study published in Science Advances shares new insights into how two of the most common types of chimeric antigen receptor (CAR) T cells kill cancer. Investigators from Baylor College of Medicine, ...

An FDA announcement last year of an investigation into the risk of patients developing secondary cancers following the treatment of CAR-T cell therapies sent shock waves across the industry. The probe ...